Elekta AB is a low-risk healthcare company based in Sweden, specializing in developing, manufacturing, and distributing treatment planning systems for neurosurgery and radiotherapy. With an ESG score of 17.9, Elekta has an installed base of over 7,000 linear accelerators, Gamma Knife, Unity platforms, and brachytherapy installations. The company's sales are well-distributed globally, with North and South America accounting for 31%, Europe, the Middle East, and Africa for 35%, and the Asia-Pacific region for the rest.